Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk

Randomized clinical trials with statins and other lipid-lowering drugs have shown the presence of a “residual cardiovascular risk” in those treated to “target” for LDL-cholesterol. This risk is mainly associated to lipid components other than LDL and in particular to remnant cholesterol (RC) and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Baratta, Francesco, Cocomello, Nicholas, Coronati, Mattia, Ferro, Domenico, Pastori, Daniele, Angelico, Francesco, Ben, Maria Del
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002331/
https://www.ncbi.nlm.nih.gov/pubmed/36901696
http://dx.doi.org/10.3390/ijms24054268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002331/
https://www.ncbi.nlm.nih.gov/pubmed/36901696
http://dx.doi.org/10.3390/ijms24054268

Ejemplares similares